QQQ   282.67 (+0.78%)
AAPL   116.40 (+1.17%)
MSFT   214.12 (+1.92%)
FB   283.76 (+2.40%)
GOOGL   1,593.11 (+0.56%)
AMZN   3,273.98 (+2.09%)
TSLA   423.64 (+0.80%)
NVDA   532.64 (+1.33%)
BABA   318.63 (+3.83%)
CGC   18.76 (+1.24%)
GE   7.16 (-2.98%)
MU   52.02 (-0.23%)
AMD   78.20 (-4.90%)
T   27.12 (-0.95%)
F   7.99 (-0.50%)
ACB   4.09 (-7.05%)
GILD   59.87 (-0.15%)
NFLX   487.95 (-0.06%)
NIO   27.60 (+6.11%)
BA   156.76 (-2.53%)
DIS   123.88 (-0.15%)
QQQ   282.67 (+0.78%)
AAPL   116.40 (+1.17%)
MSFT   214.12 (+1.92%)
FB   283.76 (+2.40%)
GOOGL   1,593.11 (+0.56%)
AMZN   3,273.98 (+2.09%)
TSLA   423.64 (+0.80%)
NVDA   532.64 (+1.33%)
BABA   318.63 (+3.83%)
CGC   18.76 (+1.24%)
GE   7.16 (-2.98%)
MU   52.02 (-0.23%)
AMD   78.20 (-4.90%)
T   27.12 (-0.95%)
F   7.99 (-0.50%)
ACB   4.09 (-7.05%)
GILD   59.87 (-0.15%)
NFLX   487.95 (-0.06%)
NIO   27.60 (+6.11%)
BA   156.76 (-2.53%)
DIS   123.88 (-0.15%)
QQQ   282.67 (+0.78%)
AAPL   116.40 (+1.17%)
MSFT   214.12 (+1.92%)
FB   283.76 (+2.40%)
GOOGL   1,593.11 (+0.56%)
AMZN   3,273.98 (+2.09%)
TSLA   423.64 (+0.80%)
NVDA   532.64 (+1.33%)
BABA   318.63 (+3.83%)
CGC   18.76 (+1.24%)
GE   7.16 (-2.98%)
MU   52.02 (-0.23%)
AMD   78.20 (-4.90%)
T   27.12 (-0.95%)
F   7.99 (-0.50%)
ACB   4.09 (-7.05%)
GILD   59.87 (-0.15%)
NFLX   487.95 (-0.06%)
NIO   27.60 (+6.11%)
BA   156.76 (-2.53%)
DIS   123.88 (-0.15%)
QQQ   282.67 (+0.78%)
AAPL   116.40 (+1.17%)
MSFT   214.12 (+1.92%)
FB   283.76 (+2.40%)
GOOGL   1,593.11 (+0.56%)
AMZN   3,273.98 (+2.09%)
TSLA   423.64 (+0.80%)
NVDA   532.64 (+1.33%)
BABA   318.63 (+3.83%)
CGC   18.76 (+1.24%)
GE   7.16 (-2.98%)
MU   52.02 (-0.23%)
AMD   78.20 (-4.90%)
T   27.12 (-0.95%)
F   7.99 (-0.50%)
ACB   4.09 (-7.05%)
GILD   59.87 (-0.15%)
NFLX   487.95 (-0.06%)
NIO   27.60 (+6.11%)
BA   156.76 (-2.53%)
DIS   123.88 (-0.15%)
Log in
NASDAQ:ISEE

IVERIC bio News Headlines

$6.20
+0.23 (+3.85 %)
(As of 10/27/2020 01:55 PM ET)
Add
Compare
Today's Range
$5.97
Now: $6.20
$6.20
50-Day Range
$4.46
MA: $5.71
$6.38
52-Week Range
$1.53
Now: $6.20
$8.97
Volume8,833 shs
Average Volume798,582 shs
Market Capitalization$554.91 million
P/E RatioN/A
Dividend YieldN/A
Beta1.72

Headlines

IVERIC bio (NASDAQ ISEE) News Headlines Today

Source:
DateHeadline
IVERIC bio (ISEE) Scheduled to Post Earnings on MondayIVERIC bio (ISEE) Scheduled to Post Earnings on Monday
americanbankingnews.com - October 27 at 12:13 PM
IVERIC bio to Report Third Quarter 2020 Financial Results and Host Conference Call on Monday, November 2, 2020IVERIC bio to Report Third Quarter 2020 Financial Results and Host Conference Call on Monday, November 2, 2020
finance.yahoo.com - October 26 at 9:22 AM
4 Health Stocks Stonepine Capital Loves (1 Has Gained 233% Since September 29)4 Health Stocks Stonepine Capital Loves (1 Has Gained 233% Since September 29)
finance.yahoo.com - October 26 at 9:22 AM
IVERIC bio, Inc. (NASDAQ:ISEE) Receives Consensus Rating of "Buy" from BrokeragesIVERIC bio, Inc. (NASDAQ:ISEE) Receives Consensus Rating of "Buy" from Brokerages
americanbankingnews.com - October 22 at 1:46 AM
Stocks Advance on "Optimistic" Turn in Stimulus TalksStocks Advance on "Optimistic" Turn in Stimulus Talks
nasdaq.com - October 21 at 12:10 PM
IVERIC bio (NASDAQ:ISEE) Shares Gap Down to $6.38IVERIC bio (NASDAQ:ISEE) Shares Gap Down to $6.38
americanbankingnews.com - October 20 at 12:07 PM
IVERIC bio (NASDAQ:ISEE) Stock Price Down 7.2%IVERIC bio (NASDAQ:ISEE) Stock Price Down 7.2%
americanbankingnews.com - October 19 at 7:48 PM
IVERIC bio, Inc. (NASDAQ:ISEE) Short Interest Up 23.2% in SeptemberIVERIC bio, Inc. (NASDAQ:ISEE) Short Interest Up 23.2% in September
americanbankingnews.com - October 19 at 1:36 AM
IVERIC bio (ISEE) Catches Eye: Stock Jumps 6.8%IVERIC bio (ISEE) Catches Eye: Stock Jumps 6.8%
finance.yahoo.com - October 16 at 2:28 PM
IVERIC bio (NASDAQ:ISEE) Shares Up 6.8%IVERIC bio (NASDAQ:ISEE) Shares Up 6.8%
americanbankingnews.com - October 15 at 6:59 PM
IVERIC bio (NASDAQ:ISEE) Trading Down 5.9%IVERIC bio (NASDAQ:ISEE) Trading Down 5.9%
americanbankingnews.com - October 12 at 7:38 PM
-$0.21 Earnings Per Share Expected for IVERIC bio, Inc. (NASDAQ:ISEE) This Quarter-$0.21 Earnings Per Share Expected for IVERIC bio, Inc. (NASDAQ:ISEE) This Quarter
americanbankingnews.com - October 6 at 5:28 PM
IVERIC bio Inc (NASDAQ:ISEE) Short Interest Up 13.3% in SeptemberIVERIC bio Inc (NASDAQ:ISEE) Short Interest Up 13.3% in September
americanbankingnews.com - October 3 at 11:29 AM
IVERIC bio, Inc. (ISEE): Hedge Funds Are Snapping UpIVERIC bio, Inc. (ISEE): Hedge Funds Are Snapping Up
finance.yahoo.com - September 15 at 3:37 AM
IVERIC bio to Participate in Upcoming September Investor / Industry ConferencesIVERIC bio to Participate in Upcoming September Investor / Industry Conferences
finance.yahoo.com - September 3 at 12:52 PM
IVERIC bio Announces Publication of GATHER1 Phase 3 Clinical Trial Results for Zimura® in Geographic Atrophy Secondary to Age-related Macular Degeneration, in Ophthalmology®, the Journal of the American Academy of OphthalmologyIVERIC bio Announces Publication of GATHER1 Phase 3 Clinical Trial Results for Zimura® in Geographic Atrophy Secondary to Age-related Macular Degeneration, in Ophthalmology®, the Journal of the American Academy of Ophthalmology
finance.yahoo.com - September 1 at 1:26 PM
IVERIC bio, Inc. (ISEE) CEO Glenn Sblendorio on Q2 2020 Results - Earnings Call TranscriptIVERIC bio, Inc. (ISEE) CEO Glenn Sblendorio on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 5 at 1:40 PM
IVERIC bio EPS misses by $0.01IVERIC bio EPS misses by $0.01
seekingalpha.com - August 5 at 8:39 AM
IVERIC bio to Present at the 2020 Wedbush PacGrow Healthcare Virtual ConferenceIVERIC bio to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
finance.yahoo.com - August 4 at 12:31 PM
IVERIC bio Inc.IVERIC bio Inc.
www.marketwatch.com - July 30 at 6:46 PM
IVERIC bio to Report Second Quarter 2020 Financial Results and Host Conference Call on Wednesday, August 5, 2020IVERIC bio to Report Second Quarter 2020 Financial Results and Host Conference Call on Wednesday, August 5, 2020
finance.yahoo.com - July 29 at 12:16 PM
What You Need To Know About IVERIC bio, Inc.s (NASDAQ:ISEE) Investor CompositionWhat You Need To Know About IVERIC bio, Inc.'s (NASDAQ:ISEE) Investor Composition
finance.yahoo.com - July 27 at 10:59 PM
What You Need To Know About IVERIC bio, Inc.'s (NASDAQ:ISEE) Investor CompositionWhat You Need To Know About IVERIC bio, Inc.'s (NASDAQ:ISEE) Investor Composition
finance.yahoo.com - July 27 at 5:56 PM
Did Hedge Funds Make The Right Call On IVERIC bio, Inc. (ISEE)Did Hedge Funds Make The Right Call On IVERIC bio, Inc. (ISEE)
finance.yahoo.com - July 17 at 2:12 PM
Did Hedge Funds Make The Right Call On IVERIC bio, Inc. (ISEE) ?Did Hedge Funds Make The Right Call On IVERIC bio, Inc. (ISEE) ?
finance.yahoo.com - July 17 at 2:12 PM
IVERIC bio Announces the Addition of Mark S. Blumenkranz, M.D., M.M.S., to its Board of DirectorsIVERIC bio Announces the Addition of Mark S. Blumenkranz, M.D., M.M.S., to its Board of Directors
finance.yahoo.com - July 16 at 8:50 AM
Moving Average Crossover Alert: IVERIC bioMoving Average Crossover Alert: IVERIC bio
finance.yahoo.com - July 3 at 8:23 AM
Iverics Trial Progress And Other News: The Good, Bad And Ugly Of BiopharmaIveric's Trial Progress And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - July 2 at 9:21 AM
Iveric bio launches second pivotal study of Zimura in eye disorderIveric bio launches second pivotal study of Zimura in eye disorder
seekingalpha.com - June 30 at 12:13 PM
IVERIC bio Announces First Patient Dosed in Second Zimura® Phase 3 Clinical Trial for the Treatment of Geographic Atrophy Secondary to Age-Related Macular DegenerationIVERIC bio Announces First Patient Dosed in Second Zimura® Phase 3 Clinical Trial for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration
finance.yahoo.com - June 30 at 12:13 PM
IVERIC bio, Inc. Announces Closing of Public Offering and Concurrent Private Placement with $160 Million in Gross ProceedsIVERIC bio, Inc. Announces Closing of Public Offering and Concurrent Private Placement with $160 Million in Gross Proceeds
finance.yahoo.com - June 22 at 6:02 PM
Why Iveric Bio Is Skyrocketing 24% TodayWhy Iveric Bio Is Skyrocketing 24% Today
www.fool.com - June 18 at 5:49 PM
Iveric bio prices equity offeringIveric bio prices equity offering
seekingalpha.com - June 18 at 7:49 AM
IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded WarrantsIVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants
finance.yahoo.com - June 18 at 1:12 AM
IVERIC bio, Inc. Announces Proposed Offering of Common Stock and Pre-Funded Warrants and Concurrent Private PlacementIVERIC bio, Inc. Announces Proposed Offering of Common Stock and Pre-Funded Warrants and Concurrent Private Placement
finance.yahoo.com - June 17 at 8:12 PM
Is IVERIC bio, Inc. (ISEE) Going to Burn These Hedge Funds?Is IVERIC bio, Inc. (ISEE) Going to Burn These Hedge Funds?
finance.yahoo.com - June 16 at 1:08 PM
Why Shares of Micro-Cap Biopharma IVERIC Bio Are Ripping HigherWhy Shares of Micro-Cap Biopharma IVERIC Bio Are Ripping Higher
www.benzinga.com - June 15 at 10:50 AM
Iveric Bios Zimura shows sustained benefit in eye disorder studyIveric Bio's Zimura shows sustained benefit in eye disorder study
seekingalpha.com - June 15 at 9:07 AM
IVERIC bio Announces Positive Zimura 18 Month Data Supporting the 12 Month Efficacy Findings: Continuous Positive Treatment Effect with Favorable Safety Profile in Geographic Atrophy Secondary to Age-Related Macular Degeneration in a Phase 3 TrialIVERIC bio Announces Positive Zimura 18 Month Data Supporting the 12 Month Efficacy Findings: Continuous Positive Treatment Effect with Favorable Safety Profile in Geographic Atrophy Secondary to Age-Related Macular Degeneration in a Phase 3 Trial
finance.yahoo.com - June 15 at 9:07 AM
IVERIC bio to Present at the Jefferies 2020 Healthcare ConferenceIVERIC bio to Present at the Jefferies 2020 Healthcare Conference
finance.yahoo.com - May 27 at 8:37 AM
Baker Brothers Snap Up These 3 Small-Cap Biotech StocksBaker Brothers Snap Up These 3 Small-Cap Biotech Stocks
finance.yahoo.com - May 26 at 2:10 PM
Why IVERIC bio (ISEE) Stock Might be a Great PickWhy IVERIC bio (ISEE) Stock Might be a Great Pick
finance.yahoo.com - May 21 at 1:52 PM
IVERIC bio, Inc. (ISEE) CEO Glenn Sblendorio on Q1 2020 Results - Earnings Call TranscriptIVERIC bio, Inc. (ISEE) CEO Glenn Sblendorio on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 7 at 4:02 PM
IVERIC bio EPS beats by $0.11IVERIC bio EPS beats by $0.11
seekingalpha.com - May 6 at 11:02 AM
IVERIC bio to Report First Quarter 2020 Financial Results and Host Conference Call on Wednesday, May 6, 2020IVERIC bio to Report First Quarter 2020 Financial Results and Host Conference Call on Wednesday, May 6, 2020
finance.yahoo.com - April 28 at 8:40 AM
Iveric bios Zimura Fast Trackd for macular degenerationIveric bio's Zimura Fast Track'd for macular degeneration
seekingalpha.com - April 3 at 5:34 PM
IVERIC bio Announces Fast Track Designation from U.S. FDA for Zimura® for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular DegenerationIVERIC bio Announces Fast Track Designation from U.S. FDA for Zimura® for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
finance.yahoo.com - April 3 at 5:34 PM
New business chief at Iveric bioNew business chief at Iveric bio
seekingalpha.com - March 23 at 6:18 PM
IVERIC bio Appoints Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business OfficerIVERIC bio Appoints Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officer
finance.yahoo.com - March 23 at 6:18 PM
Iveric bio delays start of second Zimura study due to Covid-19Iveric bio delays start of second Zimura study due to Covid-19
seekingalpha.com - March 18 at 1:47 PM
This page was last updated on 10/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.